Using these strategies, we describe an immunosuppression regimen for kidney transplantation that might be only a third of the cost of current 'standard' regimens in the USA. Such a regimen might ...
Investigators assessed frailty prevalence in a nationally representative US cohort and inpatient outcomes among kidney transplant recipients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback